StarProofed
Gabe Medico
Salesianum Sallies

Gabe Medico

Football · Offensive Tackle · Class of 2027 · 3-star
Total Brand Value
Not public
Social Media Value
Not public
Est. NIL Value
Not public
Recruiting Rank
Natl #2395
Height / Weight
6-5 · 260
Hometown
Wilmington, DE
Claim Profile

About Gabe

Gabe Medico is a offensive tackle in the class of 2027 who plays at Salesianum in Wilmington, DE. A 3-star recruit, he is ranked No. 2395 nationally and No. 177 at his position, and No. 5 in his state. He is listed at 6-5 and 260 pounds. Programs showing reported interest include Delaware, Duke, and Liberty.

Scouting Report

Scouting report is not available currently.

NIL / Brand

NIL / Brand report is not available currently.

Recruiting Profile

Status
Committed
Rankings
Stars
★★★
National
#2395
Position
#177
State
#5
Reported Team Interest
Delaware · CommittedDuke · OfferedLiberty · Offered
Methodology

How Gabe's Brand Value Is Calculated

A public NIL valuation is not available for Gabe Medico. Financial terms of NIL activity are often private.

Frequently Asked Questions

What is Gabe Medico's NIL value?+

Gabe Medico does not have a publicly available NIL valuation at this time. NIL compensation is often private, and estimates are only published for players with sufficient public data.

What school does Gabe Medico play for?+

Gabe Medico plays at Salesianum and is a class of 2027 recruit. He has not publicly committed to a college program.

What position does Gabe Medico play?+

Gabe Medico plays offensive tackle (OT) and is ranked No. 177 nationally at the position.

Where is Gabe Medico from?+

Gabe Medico is from Wilmington, DE and attended Salesianum.

How is Gabe Medico ranked as a recruit?+

Gabe Medico is rated a 3-star recruit, ranked No. 2395 nationally in his class and No. 5 in his state.

NIL values shown are estimates based on publicly available information, including social reach and reported partnerships — they are not confirmed compensation. Reported deals are based on public sources; financial terms of most deals are not publicly disclosed. Estimated values originate from a third-party published valuation model.